Cardiolink Medical Recognized as One of the '2024 Greater Bay Area High-Growth Enterprises Top 100'

On November 1, the "2024 Greater Bay Area Innovation Economy Forum," guided by the Southern Finance Media Group and jointly organized by the Guangdong-Hong Kong-Macao Greater Bay Area Research Institute and the Shenzhen Venture Capital Association, was successfully held in Shenzhen. During the event, the "2024 Greater Bay Area Innovation Power Development Report" and the "2024 Greater Bay Area Top 100 High-Growth Companies" were released. Cardiolink Science (Shenzhen) Medical Technology Development Co., Ltd. was successfully selected for its outstanding contributions and rapid growth in the medical device field.

The list aims to focus on the strategic emerging industry clusters that are key developments in the Greater Bay Area. By establishing innovative momentum and high-growth standards for enterprises in the area, it conducts a comprehensive evaluation of new industries, technologies, business formats, and models. It seeks to identify and honor outstanding high-growth enterprises of the year in the Greater Bay Area, fully showcasing benchmark cases of new momentum in the region's industries.